(Q38926824)

English

Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells

scientific article published on 20 December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Bingyu Guo

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Tingting Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Jingyuan Su

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Kaiwen Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Xiaoming Li

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

20 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

353-363

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

https://scigraph.springernature.com/pub.10.1007/s00280-014-2651-1

0 references

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Chronopharmacology and mechanism of antitumor effect of erlotinib in Lewis tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Expression of epidermal growth factor receptor in gastric carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Comparison of fractional flow reserve of composite Y-grafts with saphenous vein or right internal thoracic arteries

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Androgen receptor and invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Uterine cervical carcinoma: role of matrix metalloproteinases (review).

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2651-1

21 January 2018

Identifiers

10.1007/S00280-014-2651-1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38926824&oldid=1796796631"